These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2674825)

  • 1. Attempts of tissue typing from human donor eyes.
    Baumgartner I; Huber-Spitzy V; Grabner G; Mayr WR
    Ophthalmic Res; 1989; 21(3):268-71. PubMed ID: 2674825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA typing from human donor eyes.
    Baumgartner I; Huber-Spitzy V; Grabner G; Mayr WR
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(6):541-3. PubMed ID: 2625211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal pigment epithelial cells in post mortem HLA typing of corneal donors.
    Baumgartner I; Asenbauer TT; Kaminski SL; Grabner G; Mayr WR
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1940-5. PubMed ID: 1582799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal grafting--strategy for optimal results.
    Baumgartner I; Mayr WR; Grabner G
    Tissue Antigens; 1989 Jul; 34(1):5-8. PubMed ID: 2815057
    [No Abstract]   [Full Text] [Related]  

  • 5. [Postmortem serologic and biochemical HLA typing with cultivated retinal pigment epithelium cells].
    Nölle B; Halene M; Zavazava N; Westphal E; Duncker G; Müller-Ruchholtz W
    Fortschr Ophthalmol; 1991; 88(6):629-32. PubMed ID: 1794780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-mortem HLA tissue typing of retinal pigment epithelial cells.
    Zavazava N; Westphal E; Duncker G; Nölle B; Müller-Ruchholtz W
    Scand J Immunol Suppl; 1992; 11():192-4. PubMed ID: 1514040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA typing in high risk keratoplasty].
    Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
    Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of the DNA-HLA class II typing in corneal transplantation].
    Shimazaki J; Tsubota K; Tsuchida F; Sato T; Hagihara M; Tsuji K
    Nippon Ganka Gakkai Zasshi; 1995 Nov; 99(11):1248-53. PubMed ID: 8533654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA typing of donor corneas with extended post mortem time].
    Ventura AC; Böhnke M; Löliger C; Kühnl P; Winter R; Engelmann K
    Ophthalmologe; 1996 Jun; 93(3):262-7. PubMed ID: 8753989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ELISA-based crossmatch procedure to detect donor-specific anti-HLA antibodies responsible for corneal allograft rejections.
    Sel S; Schlaf G; Schurat O; Altermann WW
    J Immunol Methods; 2012 Jul; 381(1-2):23-31. PubMed ID: 22561526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the rejection reaction against corneal grafts and first trails with tissue-typed and HLA-adapted donor material (author's transl)].
    Kok-van Alphen CC; Völker-Dieben HJ
    Klin Monbl Augenheilkd; 1978 Aug; 173(2):208-14. PubMed ID: 359905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial experience with HLA typing in high-risk keratoplasty].
    Halás M; Oláh Z; Bencová M
    Cesk Oftalmol; 1992 Mar; 48(2):92-5. PubMed ID: 1525885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-donor antibodies in allogeneic cornea transplantation.
    Zavazava N; Duncker G; Jenisch S; Nölle B; Westphal E; Müller-Ruchholtz W
    Transplant Proc; 1995 Feb; 27(1):1410-1. PubMed ID: 7878928
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of tissue typing in corneal transplantation.
    Allansmith MR; Drell D; Kajiyama G; Fine M
    Mod Probl Ophthalmol; 1976; 16():167-74. PubMed ID: 765781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histocompatibility typing and corneal transplantation.
    Allansmith MR; Fine M; Payne R
    Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(3):OP445-60. PubMed ID: 4601136
    [No Abstract]   [Full Text] [Related]  

  • 16. Private and public HLA determinant specificities matching in corneal transplantation.
    Roy R; Boisjoly HM; Dubé I; Bernard PM; Desbiens C
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3139-41. PubMed ID: 2468252
    [No Abstract]   [Full Text] [Related]  

  • 17. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group.
    Arch Ophthalmol; 1992 Oct; 110(10):1392-403. PubMed ID: 1417537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation antigens and keratoplasty.
    Stark WJ
    Dev Ophthalmol; 1981; 5():33-40. PubMed ID: 6177566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA typing and corneal grafts].
    Duchesne B
    Bull Soc Belge Ophtalmol; 1993; 247(1):29-32. PubMed ID: 8205333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Typing for HLA matching. Advantages for keratoplasty].
    Ignatius R; Hoffmann F
    Ophthalmologe; 2007 Mar; 104(3):213-8. PubMed ID: 17353999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.